Total Payments
$2,274
2024 Payments
$431.74
Companies
42
Transactions
119
Medicare Patients
8,463
Medicare Billing
$401,437
Payment Breakdown by Category
Food & Beverage$2,259 (99.3%)
Education$15.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,259 | 118 | 99.3% |
| Education | $15.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $179.50 | 7 | $0 (2024) |
| Incyte Corporation | $163.31 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $156.89 | 10 | $0 (2024) |
| Daiichi Sankyo Inc. | $151.79 | 8 | $0 (2024) |
| Amgen Inc. | $140.41 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $140.28 | 8 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $137.72 | 7 | $0 (2024) |
| Seagen Inc. | $134.63 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $110.02 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $92.57 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $431.74 | 19 | Alexion Pharmaceuticals, Inc. ($63.46) |
| 2023 | $397.81 | 20 | Alexion Pharmaceuticals, Inc. ($57.59) |
| 2022 | $733.04 | 36 | Amgen Inc. ($140.41) |
| 2021 | $470.44 | 28 | AstraZeneca Pharmaceuticals LP ($57.94) |
| 2020 | $159.97 | 11 | Daiichi Sankyo Inc. ($41.47) |
| 2019 | $66.25 | 4 | AstraZeneca Pharmaceuticals LP ($29.97) |
| 2017 | $15.00 | 1 | Sandoz Inc. ($15.00) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.51 | General |
| 11/04/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Rare Disease | ||||||
| 10/01/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Wound Care | ||||||
| 07/18/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: HEMATOLOGY | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: HEMATOLOGY | ||||||
| 04/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: Rare Disease | ||||||
| 02/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Hematology/Oncology | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Hematology | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 01/17/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Oncology | ||||||
| 12/21/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 12/13/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Oncology | ||||||
| 12/06/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: HEMATOLOGY | ||||||
| 11/08/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: Interventional Oncology | ||||||
| 10/18/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,867 | 3,108 | $595,718 | $67,554 |
| 2022 | 20 | 1,930 | 3,886 | $547,172 | $67,855 |
| 2021 | 21 | 2,127 | 4,298 | $593,985 | $100,171 |
| 2020 | 27 | 2,539 | 5,409 | $848,197 | $165,857 |
Total Patients
8,463
Total Services
16,701
Medicare Billing
$401,437
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 179 | 191 | $44,880 | $7,530 | 16.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 227 | 253 | $51,378 | $6,702 | 13.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 115 | 119 | $40,853 | $4,631 | 11.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 138 | 150 | $30,347 | $4,310 | 14.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 75 | $17,668 | $3,340 | 18.9% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 149 | 156 | $48,182 | $2,909 | 6.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Facility | 2023 | 22 | 23 | $21,685 | $2,886 | 13.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2023 | 12 | 12 | $18,142 | $2,694 | 14.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 61 | 61 | $20,858 | $2,519 | 12.1% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Facility | 2023 | 33 | 37 | $31,129 | $2,433 | 7.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Facility | 2023 | 26 | 30 | $16,670 | $2,128 | 12.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 63 | 63 | $15,155 | $2,068 | 13.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Facility | 2023 | 35 | 42 | $18,890 | $1,843 | 9.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 18 | 18 | $16,929 | $1,818 | 10.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 87 | 88 | $27,059 | $1,621 | 6.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 52 | 88 | $14,435 | $1,373 | 9.5% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Facility | 2023 | 11 | 11 | $10,993 | $1,345 | 12.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 26 | $11,820 | $1,286 | 10.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 18 | $9,960 | $1,221 | 12.3% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 17 | $9,532 | $1,208 | 12.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 34 | 34 | $8,081 | $1,130 | 14.0% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Facility | 2023 | 11 | 11 | $10,509 | $1,083 | 10.3% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 16 | 19 | $9,784 | $1,037 | 10.6% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Facility | 2023 | 21 | 27 | $11,554 | $1,021 | 8.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 175 | 785 | $14,589 | $999.06 | 6.8% |
About Dr. Eric Wyatt, MD
Dr. Eric Wyatt, MD is a Procedural Dermatology healthcare provider based in Lawton, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417007139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Wyatt, MD has received a total of $2,274 in payments from pharmaceutical and medical device companies, with $431.74 received in 2024. These payments were reported across 119 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($2,259).
As a Medicare-enrolled provider, Wyatt has provided services to 8,463 Medicare beneficiaries, totaling 16,701 services with total Medicare billing of $401,437. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Lawton, OK
- Active Since 01/12/2007
- Last Updated 09/09/2018
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1417007139
Products in Payments
- LIBTAYO (Biological) $178.64
- ULTOMIRIS (Biological) $165.48
- MONJUVI (Drug) $130.76
- MONOFERRIC (Drug) $100.00
- Nplate (Biological) $87.27
- PROMACTA (Drug) $82.54
- INJECTAFER (Drug) $82.54
- NINLARO (Drug) $73.57
- XALKORI (Drug) $55.26
- PADCEV (Biological) $54.01
- XPOVIO (Drug) $51.20
- ADCETRIS (Biological) $47.44
- JAKAFI (Drug) $47.00
- IMBRUVICA (Drug) $46.60
- Enhertu (Drug) $39.99
- ENHERTU (Biological) $38.00
- COSELA (Drug) $36.74
- Kyprolis (Drug) $33.33
- TUKYSA (Drug) $33.18
- Tavalisse (Drug) $32.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.